PRESCIENT THERAPEUTICS LIMITED - News & Media

4.26%

4.5¢

Market Cap $36.23M

Healthcare Biotechnology

Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The... Prescient Therapeutics Limited is an Australia-based clinical-stage oncology company. The Company is developing personalized medicine approaches to cancer, including targeted and cellular therapies. Its product pipeline includes PTX-100, PTX-200, OmniCAR, CellPryme-M and CellPryme-A. PTX-100 has completed Phase Ib expansion cohort study in relapsed and refractory T cell lymphomas. PTX-200 is a PH domain inhibitor that inhibits a tumor survival pathway, Akt. OmniCAR is a universal immune receptor platform being developed to enable controllable T-cell activity and multi-antigen targeting with a single-cell product. CellPryme-M technology enhances adoptive cell therapy performance by shifting T and NK cells towards a central memory phenotype, improving persistence, and increasing the ability to find and penetrate tumors. CellPryme-A is an adjuvant therapy designed to be administered to patients alongside cellular immunotherapy to help them overcome a suppressive tumor microenvironment.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Articles & Videos

FDA grants Prescient Therapeutics (ASX:PTX) broad orphan drug status for PTX-100 cancer treatment

Oncology company Prescient Therapeutics (ASX:PTX) has been granted broad orphan drug designation (ODD) for its PTX-100 drug by the US Food and Drug Administration (FDA).

09 Mar 2023 12:08 (AEDT)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.5¢		Change -0.002(4.26%)		Mkt cap ! $36.23M

Open	High	Low	Value	Volume
4.7¢	4.7¢	4.5¢	$3.023K	65.69K

Buyers (Bids)

No.	Vol.	Price($)
2	26147	4.5¢

Sellers (Offers)

Price($)	Vol.	No.
4.8¢	100000	1

View Market Depth

No.	Vol.	Price($)
2	26147	0.045
4	120290	0.043
2	155476	0.042
3	204000	0.041
14	1327931	0.040

Price($)	Vol.	No.
0.048	100000	1
0.049	240703	3
0.051	116601	3
0.052	215000	2
0.053	300000	1

Last trade - 16.10pm 23/04/2025 (20 minute delay)

PTX (ASX) Chart